Bringing the fundamentals into focus…
Back to BridgeBio Pharma, Inc.
How BridgeBio Pharma, Inc. stacks up
BBIO · against 126 other Healthcare companies of similar size
Growth
96/ 100
Near the top of its peers.
Ranked #6 of 127 · scores higher than 95% of peers
Bars: peers in each 10-point band of the growth score17 peers with a growth score of 90–100, including BBIO · Click a bar to see the companies
Why growth scores 96?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 97% of peers. Revenue growth: 202.4% vs peer median 6.1%
- faster revenue growth over three years: stronger than 99% of peers. 3-year revenue growth: 400.9% vs peer median 5.8%
Metric by metric
Position: dot = BBIO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BBIO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 128 reported | 202.4% | 9.7% | 99% | 33% | |
| Earnings per share growthHigher is better · 92 reported | Not reported | 19.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 122 reported | 400.9% | 10.6% | 99% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around BBIO| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 21.4B USD | 97 | 67 | |
| 3 | 7.3B USD | 97 | 74 | |
| 6 | 16.5B USD | 96 | 37 | |
| 6 | 14.5B USD | 96 | 30 | |
| 8 | 9.0B USD | 95 | 51 | |
| 8 | 22.8B USD | 95 | 38 | |
| 10 | 71.0B HKD (≈$9.1B) | 94 | 54 | |
| 10 | 10.5B USD | 94 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score